Nyxoah S A (NYXH)

$6.10 -0.42 (-6.44%)
Market Cap 222.07M
Revenue (ttm) 4.89M
Net Income (ttm) -64.10M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,310.84%
Debt to Equity Ratio 0.26
Volume 90,900
Avg Vol 111,270
Day's Range N/A - N/A
Shares Out 34.06M
Stochastic %K 73%
Beta 1.53
Analysts Strong Sell
Price Target $12.75

Company Profile

Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 32 1 022 23 55
Fax: 32 1 045 90 75
Address:
Rue Edouard Belin 12, Mont-Saint-Guibert, Belgium
Hernandrod12
Hernandrod12 Oct. 7 at 8:52 PM
$NYXH $BURU $SPRB I told everyone this would happen everyone who followed me here it’s time for BURU this one is also going to explode! Do your own DD and youll see! Military tekne partnership Bullish
0 · Reply
ZacksResearch
ZacksResearch Oct. 7 at 4:48 PM
$NYXH soars 17.2% on U.S. debut of Genio system! 🚀 The first U.S. commercial implants are in, backed by strong physician demand, expanding payor coverage, and streamlined hospital approvals. This marks a pivotal step towards a potential revenue ramp for Nyxoah in the sleep apnea market. Discover the full story here 👉 https://www.zacks.com/stock/news/2763871/nyxoah-shares-rise-on-first-us-commercial-use-of-genio-system?cid=sm-stocktwits-2-2763871-body-14972&ADID=SYND_STOCKTWITS_TWEET_2_2763871_BODY_14972
0 · Reply
ZacksResearch
ZacksResearch Oct. 7 at 3:48 PM
$NYXH pops after first U.S. commercial use of its Genio system — major milestone for the company. The debut shows strong physician demand and paves the way for broader adoption in sleep apnea treatment, a big step for growth potential. See what this means for NYXH’s next phase of expansion 👉 https://www.zacks.com/stock/news/2763871/nyxoah-shares-rise-on-first-us-commercial-use-of-genio-system?cid=sm-stocktwits-2-2763871-teaser-14962&ADID=SYND_STOCKTWITS_TWEET_2_2763871_TEASER_14962
0 · Reply
topstockalerts
topstockalerts Oct. 7 at 1:20 PM
$NYXH there it goes!! 👀
0 · Reply
GrbiStock
GrbiStock Oct. 7 at 10:23 AM
$NYXH
0 · Reply
TheVirus0011
TheVirus0011 Oct. 7 at 10:11 AM
$PSTV lets go for 1$ $LASE $NYXH go to the moon
1 · Reply
topstockalerts
topstockalerts Oct. 6 at 5:34 PM
Nyxoah’s shares rose Monday after the Belgium-based medtech company announced successful first U.S. commercial implants of its Genio system for Obstructive Sleep Apnea (OSA) following FDA approval. The company reported strong initial physician demand, with surgeons seeking training and already scheduling patients. Dr. Andrew T. Huang of Baylor College of Medicine performed the first five Genio implants at Townsen Memorial System in Houston, noting comparable procedure times to initial unilateral hypoglossal nerve stimulations. CEO Olivier Taelman said Nyxoah has trained surgeons, secured value analysis approvals, and obtained reimbursement from major payers including CMS. The company is tracking metrics such as trained surgeons, committee submissions, prior-authorization requests, and new accounts as indicators of future revenue growth. $NYXH
0 · Reply
scrapplejoe
scrapplejoe Oct. 6 at 2:50 PM
$NYXH added to watchlist
0 · Reply
StocktwitsNews
StocktwitsNews Oct. 6 at 2:02 PM
US-Listed Nyxoah Shares Soar On First Genio System Implants In Patients With Sleep Disorder $NYXH $BMED $SPEU https://stocktwits.com/news/equity/markets/us-listed-nyxoah-shares-soar-on-first-genio-system-implants-in-patients-with-sleep-disorder/ch6R4LYR3g1
0 · Reply
Noobnr1
Noobnr1 Oct. 6 at 6:40 AM
$NYXH Succes in Texas with thier Genio-system🥂💤🚀 $PHAR $GILD $DVAX $PFE
0 · Reply
Latest News on NYXH
Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System

Oct 6, 2025, 1:00 AM EDT - 3 days ago

Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System

Publication relating to transparency notifications

Oct 3, 2025, 4:30 PM EDT - 5 days ago

Publication relating to transparency notifications

Nyxoah Provides an Update on Expanded Middle East Presence

Sep 23, 2025, 4:10 PM EDT - 15 days ago

Nyxoah Provides an Update on Expanded Middle East Presence

Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.

Sep 15, 2025, 4:10 PM EDT - 23 days ago

Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.

Nyxoah SA (NYXH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 10, 2025, 2:50 AM EDT - 4 weeks ago

Nyxoah SA (NYXH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Nyxoah Announces Upcoming Investor Events

Sep 2, 2025, 4:30 PM EDT - 5 weeks ago

Nyxoah Announces Upcoming Investor Events

Nyxoah: High-Risk High-Reward Medtech To Own

Aug 20, 2025, 8:00 AM EDT - 7 weeks ago

Nyxoah: High-Risk High-Reward Medtech To Own

Nyxoah SA (NYXH) Q2 2025 Earnings Call Transcript

Aug 18, 2025, 7:07 PM EDT - 7 weeks ago

Nyxoah SA (NYXH) Q2 2025 Earnings Call Transcript

Nyxoah Reports Second Quarter Financial and Operating Results

Aug 18, 2025, 4:10 PM EDT - 7 weeks ago

Nyxoah Reports Second Quarter Financial and Operating Results

Nyxoah Announces Preliminary Results for the Second Quarter of 2025

Aug 11, 2025, 1:00 AM EDT - 2 months ago

Nyxoah Announces Preliminary Results for the Second Quarter of 2025

Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea

Aug 8, 2025, 4:10 PM EDT - 2 months ago

Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025

Jul 29, 2025, 4:30 PM EDT - 2 months ago

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025

Nyxoah's DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine

Jul 28, 2025, 4:05 PM EDT - 2 months ago

Nyxoah's DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine

Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 2, 2025

Jun 13, 2025, 1:00 AM EDT - 4 months ago

Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 2, 2025

Nyxoah to Present at the Jefferies Global Healthcare Conference

May 28, 2025, 4:30 PM EDT - 4 months ago

Nyxoah to Present at the Jefferies Global Healthcare Conference

Nyxoah SA (NYXH) Q1 2025 Earnings Call Transcript

May 14, 2025, 2:35 PM EDT - 5 months ago

Nyxoah SA (NYXH) Q1 2025 Earnings Call Transcript

Nyxoah Reports First Quarter Financial and Operating Results

May 14, 2025, 1:00 AM EDT - 5 months ago

Nyxoah Reports First Quarter Financial and Operating Results

Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 11, 2025

May 9, 2025, 1:00 AM EDT - 5 months ago

Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 11, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nyxoah S.A. (NYXH) And Encourages Shareholders to Reach Out

Apr 22, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nyxoah S.A. (NYXH) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Shareholders to Learn More About the Investigation

Apr 21, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Shareholders to Learn More About the Investigation

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Apr 20, 2025, 10:00 AM EDT - 6 months ago

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Shareholders to Inquire about Securities Investigation

Apr 18, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Shareholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Investors to Connect

Apr 17, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Stockholders to Inquire about Securities Investigation

Apr 16, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Stockholders to Inquire about Securities Investigation

Conditional Issuance of Shares

Apr 16, 2025, 2:00 AM EDT - 6 months ago

Conditional Issuance of Shares

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Investors to Learn More About the Investigation

Apr 15, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Investors to Learn More About the Investigation

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Apr 14, 2025, 10:00 AM EDT - 6 months ago

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Stockholders to Connect

Apr 11, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Nyxoah S.A. (NYXH) And Encourages Stockholders to Connect

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Apr 10, 2025, 10:00 AM EDT - 6 months ago

Nyxoah S.A. (NYXH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Stockholders to Learn More About the Investigation

Apr 9, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nyxoah S.A. (NYXH) and Encourages Stockholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Investors to Inquire about Securities Investigation

Apr 8, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Nyxoah S.A. (NYXH) Investors to Inquire about Securities Investigation

Nyxoah Provides Update on FDA Approvable Letter for Genio System

Apr 8, 2025, 1:00 AM EDT - 6 months ago

Nyxoah Provides Update on FDA Approvable Letter for Genio System

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nyxoah S.A. (NYXH) And Encourages Investors to Reach Out

Apr 7, 2025, 3:00 PM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nyxoah S.A. (NYXH) And Encourages Investors to Reach Out

NYXH Investors Have Opportunity to Join Nyxoah S.A. Fraud Investigation with the Schall Law Firm

Apr 7, 2025, 9:33 AM EDT - 6 months ago

NYXH Investors Have Opportunity to Join Nyxoah S.A. Fraud Investigation with the Schall Law Firm

Nyxoah S.A. Investors: Company Investigated by the Portnoy Law Firm

Mar 31, 2025, 5:40 PM EDT - 6 months ago

Nyxoah S.A. Investors: Company Investigated by the Portnoy Law Firm

Nyxoah S.A. Being Investigated on Behalf of Nyxoah S.A.

Mar 31, 2025, 2:45 PM EDT - 6 months ago

Nyxoah S.A. Being Investigated on Behalf of Nyxoah S.A.

FDA Issues Nyxoah an Approvable Letter for its Genio® System

Mar 26, 2025, 3:00 AM EDT - 7 months ago

FDA Issues Nyxoah an Approvable Letter for its Genio® System

Nyxoah SA (NYXH) Q4 2024 Earnings Call Transcript

Mar 13, 2025, 4:45 PM EDT - 7 months ago

Nyxoah SA (NYXH) Q4 2024 Earnings Call Transcript

Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results

Mar 13, 2025, 2:00 AM EDT - 7 months ago

Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results

Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025

Mar 10, 2025, 5:05 PM EDT - 7 months ago

Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025

Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

Mar 3, 2025, 4:30 PM EST - 7 months ago

Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East

Feb 19, 2025, 1:05 AM EST - 8 months ago

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East

Nyxoah: The Future Of OSA

Dec 30, 2024, 4:01 AM EST - 10 months ago

Nyxoah: The Future Of OSA

Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England

Dec 13, 2024, 2:05 AM EST - 10 months ago

Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 20, 2024, 4:05 PM EST - 11 months ago

Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference

Hernandrod12
Hernandrod12 Oct. 7 at 8:52 PM
$NYXH $BURU $SPRB I told everyone this would happen everyone who followed me here it’s time for BURU this one is also going to explode! Do your own DD and youll see! Military tekne partnership Bullish
0 · Reply
ZacksResearch
ZacksResearch Oct. 7 at 4:48 PM
$NYXH soars 17.2% on U.S. debut of Genio system! 🚀 The first U.S. commercial implants are in, backed by strong physician demand, expanding payor coverage, and streamlined hospital approvals. This marks a pivotal step towards a potential revenue ramp for Nyxoah in the sleep apnea market. Discover the full story here 👉 https://www.zacks.com/stock/news/2763871/nyxoah-shares-rise-on-first-us-commercial-use-of-genio-system?cid=sm-stocktwits-2-2763871-body-14972&ADID=SYND_STOCKTWITS_TWEET_2_2763871_BODY_14972
0 · Reply
ZacksResearch
ZacksResearch Oct. 7 at 3:48 PM
$NYXH pops after first U.S. commercial use of its Genio system — major milestone for the company. The debut shows strong physician demand and paves the way for broader adoption in sleep apnea treatment, a big step for growth potential. See what this means for NYXH’s next phase of expansion 👉 https://www.zacks.com/stock/news/2763871/nyxoah-shares-rise-on-first-us-commercial-use-of-genio-system?cid=sm-stocktwits-2-2763871-teaser-14962&ADID=SYND_STOCKTWITS_TWEET_2_2763871_TEASER_14962
0 · Reply
topstockalerts
topstockalerts Oct. 7 at 1:20 PM
$NYXH there it goes!! 👀
0 · Reply
GrbiStock
GrbiStock Oct. 7 at 10:23 AM
$NYXH
0 · Reply
TheVirus0011
TheVirus0011 Oct. 7 at 10:11 AM
$PSTV lets go for 1$ $LASE $NYXH go to the moon
1 · Reply
topstockalerts
topstockalerts Oct. 6 at 5:34 PM
Nyxoah’s shares rose Monday after the Belgium-based medtech company announced successful first U.S. commercial implants of its Genio system for Obstructive Sleep Apnea (OSA) following FDA approval. The company reported strong initial physician demand, with surgeons seeking training and already scheduling patients. Dr. Andrew T. Huang of Baylor College of Medicine performed the first five Genio implants at Townsen Memorial System in Houston, noting comparable procedure times to initial unilateral hypoglossal nerve stimulations. CEO Olivier Taelman said Nyxoah has trained surgeons, secured value analysis approvals, and obtained reimbursement from major payers including CMS. The company is tracking metrics such as trained surgeons, committee submissions, prior-authorization requests, and new accounts as indicators of future revenue growth. $NYXH
0 · Reply
scrapplejoe
scrapplejoe Oct. 6 at 2:50 PM
$NYXH added to watchlist
0 · Reply
StocktwitsNews
StocktwitsNews Oct. 6 at 2:02 PM
US-Listed Nyxoah Shares Soar On First Genio System Implants In Patients With Sleep Disorder $NYXH $BMED $SPEU https://stocktwits.com/news/equity/markets/us-listed-nyxoah-shares-soar-on-first-genio-system-implants-in-patients-with-sleep-disorder/ch6R4LYR3g1
0 · Reply
Noobnr1
Noobnr1 Oct. 6 at 6:40 AM
$NYXH Succes in Texas with thier Genio-system🥂💤🚀 $PHAR $GILD $DVAX $PFE
0 · Reply
Noobnr1
Noobnr1 Oct. 1 at 9:19 AM
$NYXH it’s will be a huge company soon 🚀 $GILD $PFE $PHAR Fast judgement by FDA = approval very soon 🥳🥳
0 · Reply
topstockalerts
topstockalerts Sep. 28 at 12:20 PM
After Hours Top Gainers PT2 $ZTEK $OSRH $EVTV $NYXH $SOND
1 · Reply
topstockalerts
topstockalerts Sep. 27 at 1:24 PM
After Hours Top Gainers PT2 $ZTEK $OSRH $EVTV $NYXH $SOND
0 · Reply
topstockalerts
topstockalerts Sep. 26 at 9:57 PM
After Hours Top Gainers PT2 $PAVS $NYXH $SGBX $MNDR $FOFO
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Sep. 24 at 10:08 AM
WATCHLIST SEP 24 2025. $DEFT DeFi Technologies' Valour Launches Thirteen New ETPs On Spotlight, Reaching 99 Listed And Bolstering Global Digital Asset Leadership $KBR KBR To Spin Off Mission Technology Solutions, Creating Two Independent Pure-Play Companies Focused On Engineering, National Security And Space $NYXH Nyxoah Announces Continued Expansion Of Commercial Footprint In Middle East, Following First Genio Implant In Abu Dhabi In September 2025 $WFRD Weatherford Awarded 8-Yr Contract By SNGN Romgaz To Deliver Services For Real-Time Monitoring And Transmission Of Dynamic Parameters From Wellheads Of Gas Wells $SHFS SHF Holdings shares are trading higher after the company announced it entered into a $150 million common stock purchase agreement with CREO.
0 · Reply
TheVirus0011
TheVirus0011 Sep. 19 at 8:49 AM
$NYXH +6.20% in belgium :-)
0 · Reply
TheVirus0011
TheVirus0011 Sep. 15 at 10:16 PM
$NYXH Nyxoah sues Inspire Medical for patent infringement https://fr.investing.com/news/assorted/nyxoah-poursuit-inspire-medical-pour-violation-de-brevet-432SI-3050827
0 · Reply
TheVirus0011
TheVirus0011 Sep. 15 at 10:06 PM
$PSTV Do you think it's short? $VGZ $HUMA $NYXH $TSLA
0 · Reply
TheVirus0011
TheVirus0011 Sep. 9 at 9:59 PM
$PSTV need good news and good numbers to explode $HUMA $CTMCF $NYXH
2 · Reply
lou1209
lou1209 Sep. 4 at 3:32 PM
$NYXH nyxh Bruxelles in 9euro this month ☺️ dont panic.
2 · Reply
Culby
Culby Sep. 2 at 1:32 PM
$NYXH what is going on here?
0 · Reply
Couvie
Couvie Sep. 2 at 10:43 AM
$NYXH what a shit
0 · Reply